Chalazion - clinical fact sheet and MCQ
Overview
A chalazion is a chronic, non-infectious granulomatous inflammation of the eyelid caused by the obstruction of a meibomian gland and subsequent leakage of sebum into the surrounding tissues. This results in a painless, localised eyelid swelling that can persist for weeks to months. Chalazia are more common in adults though may occur at any age. They may arise secondary to blockage of the sebaceous glands of the eyelid caused by conditions such as blepharitis, ocular rosacea, or seborrhoeic dermatitis​.
Diagnosis of chalazia
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMedcast Medical Education Team
New MBS items for GP chronic condition management plans (GPCCMPs) came into effect on July 1st 2025. This Business Skills FastTrack is designed to update GP practice owners and locums about the new GPCCMP item numbers, ensuring you maximise your billing practices without compromising on compliance. 30mins each RP and EA CPD available.
Medcast Medical Education Team
GPs play a critical role in identifying patients with a suspicion of lung cancer. This FastTrack fact sheet covers screening, diagnosis, and investigation of lung cancer in primary care, including updates on the new National Lung Cancer Screening program. Earn 30mins each of RP and EA CPD with the quiz.
Medcast Medical Education Team
Age-related macular degeneration (AMD) causes half of all blindness and severe vision loss among older Australians. Though there is currently no definitive cure, early identification and intervention can help to slow disease progression and preserve sight. This FastTrack highlights the role of GPs in recognising AMD, providing primary care interventions, and when to refer.